Engineers come together!
Engineers we need you!
Are you a fully qualified Engineer with experience in
If so then we need to speak to you!
Everyday we have more and more jobs in Engineering and Science coming in the door so we may have the right career move for you!
So whether you are looking for your next career move, or move back into the Engineering field, please do get in touch!
New Jobs in!
Contrary to news reports of certain medical device companies offering voluntary redundancies due to restructuring to keep the company afloat, there are other medical device companies in the country that are in fact taking people on! Validation or Engineering anyone?
The following are the openings within Med Device at the moment:
So whether you are working at the moment or being offered redundancy and want a fresh look at the med device market at the moment, contact us here for a full job description or to register your interest in future medical device jobs!
Speak Soon!
Success for EndoFLIP!
Cropson’s EndoFLIP has had it’s first use in a new weight loss surgery technique, known as gastric imbrications.
The reversible gastric imbrications technique is a unique procedure that needs no device implanted or no tissue removed from the stomach.
The potential for success in the US is quite realistic, given the popularity for weight loss surgery in the US.
“The EndoFLIP device has the avility to change the way we do bariatric surgery all over the world” says Dr Daniel Cottam, “There has been nothing as revolutionary as this device since the lap band”.
Cottam added “I believe in five years we won’t know how we ever did bariatric surgery without it”.
EndoFLIP technology “fills an important need for the gastric imbrications procedure, namely providing visual feedback to the surgeon “, John O Dea, CEO Crospon as said.
Once again, we wish Crospon the very best of luck with their venture in the US.
Watch this space for further EndoFLIP updates!
Eland to sell off EDT
Plans to sell Elan’s drug technology business EDT may rise a portion from when Kelly Martin aimed to sell in 2008.
Elan’s EDT is said to be worth $900m should it float on the US Stock market. Elan almost sold off for $1.4bn in 2008 with a number of equities reaching the second round of bidding.
Have you Got What it Takes
Are proficient with Procedural Kits?
Have you a long standing background in QA/ RA in the Medical Device industry?
Are you up to date with Product Development and CE Marking?
We may have the perfect job for you!
We have an urgent requirement for a Procedural Kitting Director in the Midlands
If this is for you get in touch!
I would love to hear from you!
Gastric -Band Technology
Following FDA approval for their EndoFLIP product, Medical Device developer Crospon has broken into the US market.
Crospon develops medical devices within the area of gastroenterology specifically in monitoring, diagnosis and therapy.
The World Congress of Endoscopic Surgery were presented with pilot clinical trial results for the optimum stoma size for gastric band adjustment.
Following the release in the European market in 2009, EndoFLIP will now be launched in the US market.
“Gastric banding is the fastes-growing class of bariatric surgery in the US, and we believe that EndoFLIP can bring a new science to gastric-band adjustment”, says Larry Fulton, VP Sales for the Americas.
Crospon Principal investigator Dr Robert G Snow also added, “In addition, we look forward to collaborating with a number of new leading bariatric surgery study centres inside and outside of the US as we collectively seek to better define new techniques for best use of the EndoFLIP system for gastric band adjustments”.
Nanoscience gets funding
New Jobs in Irish Nanoscience Research?
Nanoscience research institute CRANN is to create new jobs in Research & Development, leading research projects including cancer research and computer chips.
The majority of these seventeen newly created positions are to be in the Institute of Molecular Medicine and TCD School of Medicine in conjunction with CRANN. This particular team will be aiming at nanomedical technology in the early diagnosis of cancer.
The remaining 5 positions are to be with Intel as CRANN focuses on developing computer chips for the next generation.
Professor John Boland, Director of CRANN says “Ireland is now globally recognised for it’s expertise in the area of nanoscience, as evidenced by the large amounts of non-exchequer funding we are winning through competitive international research projects.” He goes on to say “Research is a global competition and we need to contuinue to develop our knowledge base and expertise to make Ireland a true innovation centre”
The investment was seen as a “huge vote of confidence” by Professor Dermot Kelleher of TCD School of Medicine.
Pharmacy Pharmacy Pharmacy
Are you a qualified Pharmacist?
Have you worked in Hospital Pharmacy or Clinical Pharmacy?
We may have the job for you!
We are looking for qualified Pharmacists to fill two positions in Limerick:
Whether you are a Pharmacist, Hospital Pharmacist, Head of Pharmacy and looking for a Pharmacist position, Pharmacy job or have Hospital Pharmacy in mind we want to see your CV!
Semiconductor Wafer Fabrication Technician
Intels next generation is here. The Atom range of chips sets will power the next generation of note books and entry level PC’s and hopefuly for Intel steal a march on its major competitors- notable AMD. Original Engineering Manufacturers have already indicated their commitment to using the new processors in their systems within weeks, the NM450 and NM10 are already lined up for the Notebooks and the entry level PC’s are expected to utilise either the D410 or D510 processors.
All of this is good news for the Intel Ireland facility based at Leixlip which has seen major investment in the FAB 24 and FAB 24-2 wafer fabrication facilities which will undoutedly be ramping up to take account of increased demand in the coming months.
Leixlip has several Wafer FABbrication facilties the newest of which opened only 2 years ago and which will newly see the opening of an advanced R&D facility.
Currently Intel is upgrading and retrofitting both the FAB 10 and FAB 14 facilities which will add increased manufacturing capacity to a plant which is already operating at peak demand.
Medical Device Manufacturing- Product Development- R&D
A €30 million investment in medical devices, R&D and facilities has been made by three seperate multinationals located at three seperate locations around Ireland. This is a superb vote of confidence in Irish R&D and is yet another example of the commitment shown by multinationals to their Irish operations that will see them into and beyond 2010 .
Merit Medical Systems, Sanmina and Baxter Healthcare will continue their FDI investment program of over €30 Million in further R&D and facilties expansion projects and cover a number of disparate projects.
Merit who manufacture proprietory disposable medical devices for diagnostic and interventional procedures worldwide will be investing €20 million in a new product and upgrading others at their Galway manufacturing facility. This will lead to greater diversity and enhancements in the current production facilities and product lines and add considerable value .
Baxter Healthcare will add a €5.5 Million new CHP (Combined Heat and Power) plant to their Castlebar plant which will account for almost 75% of its energy requirements and reduce their operating costs substantially.
Elsewhere in the country, Sanmina in Fermoy are investing €10 million in their electronic medical devices manufacturing facility. Fermoy is seen as the leading R&D facility within Sanmina and will be enhancing and further developing the current R&D facilities to account and cover for outsourced design, development and manufacturing for OEM (Original Engineering Manufacturing) Clients. Sanmina will now employ just under 500 persons as a result of this investment and indicates the continued level of importance placed on the Fermoy facility within the Sanmina corporate structure.
Happy 2010 to all!
